Aurora Cannabis urges shareholders to take no action on Curaleaf’s revised hostile bid offering US$5 per share

Curaleaf revised its unsolicited bid for Aurora Cannabis, implying consideration of US$5.00 per share. Terms include 0.4013 Curaleaf subordinate voting shares per Aurora share, alongside US$1.00 cash per share. Aurora’s board special committee launched an independent review of the revised offer. Curaleaf set a revised expiry date of at least Dec. 4, 2026.